Nicolas Tsapis
6Patents
2h-index
9Co-inventors
40Inventor score
Filing activity: May 18, 2006 → Nov 16, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8048413B2 | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules | Emerging Cross-Sectional Technologies | 51 | Active |
| US8388984B2 | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules | Emerging Cross-Sectional Technologies | 9 | Active |
| US8951564B2 | Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract | Emerging Cross-Sectional Technologies | 1 | Active |
| US8106000B2 | Colonic delivery of adsorbents | Human Necessities | 1 | Active |
| US11642320B2 | Nanoparticulate prodrugs | Human Necessities | 0 | Active |
| US12150996B2 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.